Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?

Wiborg IM, Dahl AA.

Arch Gen Psychiatry. 1996 Aug;53(8):689-94.

PMID:
8694682
2.

Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.

Bakker A, van Dyck R, Spinhoven P, van Balkom AJ.

J Clin Psychiatry. 1999 Dec;60(12):831-8.

PMID:
10665629
3.

The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial.

Fahy TJ, O'Rourke D, Brophy J, Schazmann W, Sciascia S.

J Affect Disord. 1992 May;25(1):63-75. Erratum in: J Affect Disord 1992 Jul;25(3):214.

PMID:
1624646
4.

Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.

Martinsen EW, Olsen T, Tønset E, Nyland KE, Aarre TF.

J Clin Psychiatry. 1998 Aug;59(8):437-42; quiz 443.

PMID:
9721829
5.

Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine.

Feet PO, Götestam KG.

Acta Psychiatr Scand. 1994 Apr;89(4):230-4.

PMID:
7912879
6.

Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.

Modigh K, Westberg P, Eriksson E.

J Clin Psychopharmacol. 1992 Aug;12(4):251-61.

PMID:
1527228
7.
8.

Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.

Maina G, Rosso G, Bogetto F.

J Affect Disord. 2009 Apr;114(1-3):200-7. doi: 10.1016/j.jad.2008.07.010. Epub 2008 Aug 26.

9.

The Galway Study of Panic Disorder. IV. Temporal stability of diagnosis by present state examination test-retest.

O'Rourke D, Fahy TJ, Prescott P.

Br J Psychiatry. 1996 Jul;169(1):98-100.

PMID:
8818376
10.

Clomipramine treatment of panic disorder: pros and cons.

Papp LA, Schneier FR, Fyer AJ, Leibowitz MR, Gorman JM, Coplan JD, Campeas R, Fallon BA, Klein DF.

J Clin Psychiatry. 1997 Oct;58(10):423-5.

PMID:
9375591
11.

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.

Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.

J Clin Psychiatry. 1998 Oct;59(10):528-34.

PMID:
9818634
12.

Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.

Hoffart A, Due-Madsen J, Lande B, Gude T, Bille H, Torgersen S.

J Clin Psychiatry. 1993 Dec;54(12):481-7.

PMID:
8276739
13.

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.

Sasson Y, Iancu I, Fux M, Taub M, Dannon PN, Zohar J.

Eur Neuropsychopharmacol. 1999 Mar;9(3):191-6.

PMID:
10208287
14.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
15.

Panic disorder: treatment with valproate.

Woodman CL, Noyes R Jr.

J Clin Psychiatry. 1994 Apr;55(4):134-6.

PMID:
8071256
16.
17.

5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo.

Broocks A, Meyer T, Opitz M, Bartmann U, Hillmer-Vogel U, George A, Pekrun G, Wedekind D, Rüther E, Bandelow B.

Eur Neuropsychopharmacol. 2003 May;13(3):153-64.

PMID:
12729940
18.

Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.

Mavissakalian MR, Perel JM.

Arch Gen Psychiatry. 1999 Sep;56(9):821-7.

PMID:
12884888
20.

The longitudinal course and outcome of panic disorder.

Pollack MH, Smoller JW.

Psychiatr Clin North Am. 1995 Dec;18(4):785-801. Review.

PMID:
8748381

Supplemental Content

Support Center